In an initiative to reduce excessive opioid prescribing, Express Scripts Holding Company ESRX announced a 90-day analysis of its Advanced Opioid Management program. The program was initiated last ...
These five quotes from Express Scripts' second-quarter earnings conference call offer insight into whether investors should expect the business to grow or shrink. Express Scripts (ESRX) appears to ...
Compare to: Previous Statements by ESRX » Express Scripts Holding’s CEO Discusses Q1 2012 Results – Earnings Call Transcript » Express Scripts’ CEO Discusses Q4 2011 Results – Earnings Call Transcript ...
Express Scripts appears to have bitten off a bit more than it could chew with its 2012 purchase of Medco Health Solutions. During its second-quarter earnings conference call, the pharmacy benefits ...
Express Scripts (NASDAQ: ESRX) announced solid third-quarter results on Tuesday after the market closed. In its conference call on Wednesday morning, the pharmacy benefits manager (PBM) provided more ...
Tim Wentworth, Express Scripts' CEO, started off the conference call on Wednesday by underscoring that the job his company does has never been more important. Wentworth listed five market forces that ...
Express Scripts (NASDAQ: ESRX) announced solid third-quarter results on Tuesday after the market closed. In its conference call on Wednesday morning, the pharmacy benefits manager (PBM) provided more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results